Cargando…
Multiplexed CRISPR gene editing in primary human islet cells with Cas9 ribonucleoprotein
Successful genome editing in primary human islets could reveal features of the genetic regulatory landscape underlying β cell function and diabetes risk. Here, we describe a CRISPR-based strategy to interrogate functions of predicted regulatory DNA elements using electroporation of a complex of Cas9...
Autores principales: | Bevacqua, Romina J., Zhao, Weichen, Merheb, Emilio, Kim, Seung Hyun, Marson, Alexander, Gloyn, Anna L., Kim, Seung K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516051/ https://www.ncbi.nlm.nih.gov/pubmed/37745551 http://dx.doi.org/10.1101/2023.09.16.558090 |
Ejemplares similares
-
CRISPR-based genome editing in primary human pancreatic islet cells
por: Bevacqua, Romina J., et al.
Publicado: (2021) -
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021) -
Genome editing in maize directed by CRISPR–Cas9 ribonucleoprotein complexes
por: Svitashev, Sergei, et al.
Publicado: (2016) -
In Vitro Pre-validation of Gene Editing by CRISPR/Cas9 Ribonucleoprotein
por: Mehravar, Maryam, et al.
Publicado: (2019) -
CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells
por: Hildreth, Andrew D., et al.
Publicado: (2020)